Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. | Nat Cancer | 2024 | 39558146 | PubTator, text mining | PubMed |
| SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death. | Cell Mol Life Sci | 2024 | 39540935 | PubTator, text mining | PubMed |
| SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1. | Theranostics | 2024 | 39479456 | PubTator, text mining | PubMed |
| Correction: Prostate cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly. | Mol Cancer | 2024 | 39261929 | PubTator, text mining | PubMed |
| Prostate cancer genotyping for risk stratification and precision treatment. | Curr Urol | 2024 | 39176294 | PubTator, text mining | PubMed |
| YTHDF3 Regulates the Degradation and Stability of m6A-Enriched Transcripts to Facilitate the Progression of Castration-Resistant Prostate Cancer. | J Pineal Res | 2024 | 39143673 | PubTator, text mining | PubMed |
| SPOP expression is associated with tumor-infiltrating lymphocytes in pancreatic cancer. | PLoS One | 2024 | 39074086 | PubTator, text mining | PubMed |
| Deciphering the genetic and epigenetic architecture of prostate cancer. | Adv Cancer Res | 2024 | 39032950 | PubTator, text mining | PubMed |
| Ceramide-induced cleavage of GPR64 intracellular domain drives Ewing sarcoma. | Cell Rep | 2024 | 39024100 | PubTator, text mining | PubMed |
| Corrigendum to "SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway" [Neoplasia (2021) 23, 1037-1047]. | Neoplasia | 2024 | 39009486 | PubTator, text mining | PubMed |
| [A study on the association between insulin resistance and genome-wide DNA methylation based on Shanghai monozygotic twins]. | Zhonghua Liu Xing Bing Xue Za Zhi | 2024 | 39004964 | PubTator, text mining | PubMed |
| Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis. | Cell Rep | 2024 | 38968071 | PubTator, text mining | PubMed |
| Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. | Mol Cancer Res | 2024 | 38912907 | PubTator, text mining | PubMed |
| Construction and Validation of a Prognostic Model Based on Mitochondrial Genes in Prostate Cancer. | Horm Metab Res | 2024 | 38870985 | PubTator, text mining | PubMed |
| Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis. | Eur Urol Oncol | 2024 | 38704358 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer. | Eur J Med Res | 2024 | 38643190 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1. | J Exp Clin Cancer Res | 2024 | 38641828 | PubTator, text mining | PubMed |
| ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance. | Cell Death Dis | 2024 | 38632244 | PubTator, text mining | PubMed |
| Biomolecular Condensates Decipher Molecular Codes of Cell Fate: From Biophysical Fundamentals to Therapeutic Practices. | Int J Mol Sci | 2024 | 38612940 | PubTator, text mining | PubMed |
| Skraban-Deardorff intellectual disability syndrome-associated mutations in WDR26 impair CTLH E3 complex assembly. | FEBS Lett | 2024 | 38575527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=9